Director, Global Value & Market Access

This pivotal global role within the Global Value & Market Access team shapes market access, pricing, evidence-generation, and health policy strategies for Alfasigma's specialty and rare disease portfolio. The position drives the development of compelling value propositions and evidence plans to support optimal pricing, reimbursement, and patient access outcomes across key global markets. Working in close partnership with the SVP and cross-functional stakeholders, the role integrates payer, Health Technology Assessment (HTA), and health policy perspectives into asset strategy and lifecycle planning.